Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Structural requirements for ErbB2 transactivation.

E Penuel1, G Schaefer, R W Akita

  • 1Molecular Oncology Department, Genentech, Inc., One DNA Way, South San Francisco, CA 94080, USA..

Seminars in Oncology
|January 5, 2002
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Changes in the quality of life in patients undergoing orthognathic therapy - A systematic review.

Journal of cranio-maxillo-facial surgery : official publication of the European Association for Cranio-Maxillo-Facial Surgery·2023
Same author

Integrated genomic analysis of colorectal cancer progression reveals activation of EGFR through demethylation of the EREG promoter.

Oncogene·2016
Same author

Distinct ERG rearrangement prevalence in prostate cancer: higher frequency in young age and in low PSA prostate cancer.

Prostate cancer and prostatic diseases·2013
Same author

Fourier transform infrared imaging analysis in discrimination studies of squamous cell carcinoma.

The Analyst·2012
Same author

Morphological and tissue characterization of the medicinal fungus Hericium coralloides by a structural and molecular imaging platform.

The Analyst·2011
Same author

HD 181068: a red giant in a triply eclipsing compact hierarchical triple system.

Science (New York, N.Y.)·2011
Same journal

A systematic scoping review of cancer-related anemia treatment: Comparative trial outcomes, current guidelines, and future perspectives.

Seminars in oncology·2026
Same journal

Steroid-induced tumor lysis syndrome in solid tumors: A case report and review of the literature.

Seminars in oncology·2026
Same journal

PSMA PET/CT staging in intermediate-risk prostate cancer: Toward risk-adapted implementation.

Seminars in oncology·2026
Same journal

Angiogenesis and the corresponding antiangiogenic therapy in gastroenteropancreatic neuroendocrine neoplasms.

Seminars in oncology·2026
Same journal

Post-translational regulation of steroidogenesis and its clinical relevance in hormone responsive cancers.

Seminars in oncology·2026
Same journal

Physics-informed machine learning for tumor microenvironment-responsive nanomedicine: Recent updates.

Seminars in oncology·2026
See all related articles

ErbB2 receptor tyrosine kinase activation occurs without a ligand through homodimerization when overexpressed. At normal levels, ErbB2 acts as a coreceptor, requiring a specific C-terminal segment for ligand-dependent activation.

Area of Science:

  • Cellular signaling
  • Receptor tyrosine kinases
  • Molecular biology

Background:

  • ErbB2 is a unique ErbB family receptor tyrosine kinase lacking an identified ligand.
  • ErbB2 activation mechanisms differ based on expression levels and ligand presence.
  • Understanding ErbB2 activation is crucial for comprehending ErbB family signaling.

Purpose of the Study:

  • To elucidate the mechanisms of ErbB2 activation, particularly in the absence of a direct ligand.
  • To investigate the role of ErbB2 in both homodimeric and heterodimeric complexes.
  • To identify key structural components required for ErbB2 transactivation.

Main Methods:

  • Analysis of ErbB2 activation pathways under varying expression conditions.
  • Investigating the necessity of extracellular, transmembrane, and carboxy-terminal domains for ErbB2 function.

Related Experiment Videos

  • Identifying specific amino acid sequences involved in ligand-dependent transactivation.

    • Main Results:

    • Overexpressed ErbB2 activates kinase activity via constitutive homodimerization, independent of ligand.
    • At normal levels, ErbB2 functions as a coreceptor in heterodimeric complexes, activated by partner ligands.
    • A conserved three-amino-acid segment at the C-terminus is essential for ligand-dependent ErbB2 transactivation.

    Conclusions:

    • ErbB2 activation is context-dependent, involving both ligand-independent and ligand-dependent pathways.
    • The C-terminal three-amino-acid segment represents a conserved regulatory element for ErbB family signaling.
    • These findings provide insights into the complex signaling network regulated by ErbB receptors.